Use of {99m}Tc-HMPAO in Evaluating the Results of Cerebral Hypoperfusion Prevention in the Patients with Coronary Heart Disease after Coronary Artery Bypass Grafting; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)

Bibliografiske detaljer
Parent link:Advanced Materials Research : Radiation and nuclear techniques in material science: Scientific Journal
Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014).— 2015.— [P. 506-510]
Institution som forfatter: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯК)
Andre forfattere: Efimova N. Yu. Nataliya Yurievna, Chernov V. I. Vladimir Ivanovich, Efimova I. Y., Akhmedov S. D., Lishmanov Yu. B. Yury Borisovich
Summary:Title screen
The purpose of this study is to research the use of the radiopharmaceutical {99m}Tc-HMPAO in the evaluation of drug prevention of cerebral complications in patients with coronary heart disease after coronary artery bypass grafting (CABG) performed with cardiopulmonary bypass (CPB). The study included 30 patients, in whom surgical revascularization was performed with CPB. 11 patients in this group were prescribed instenon. All the patients underwent brain tomoscintigraphy with {99m}Tc-HMPAO and neuropsychological testing before CABG and 10-15 days after it. The results showed that {99m}Tc-HMPAO is useful radiopharmaceutical for evaluation of cerebral complications in patients after CABG. Thus, coronary artery bypass grafting using CPB can be complicated by the deterioration of cerebral perfusion and cognitive dysfunction, while preventive medication with instenon can prevent or significantly reduce the violations of cerebral hemodynamics and neuropsychological status of the patients.
Режим доступа: по договору с организацией-держателем ресурса
Sprog:engelsk
Udgivet: 2015
Serier:Radiation Technologies in Medicine
Fag:
Online adgang:http://dx.doi.org/10.4028/www.scientific.net/AMR.1084.506
Format: MixedMaterials Electronisk Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=640426

MARC

LEADER 00000nla2a2200000 4500
001 640426
005 20231101134120.0
035 |a (RuTPU)RU\TPU\network\4975 
035 |a RU\TPU\network\4974 
090 |a 640426 
100 |a 20150416a2015 k y0engy50 ba 
101 0 |a eng 
105 |a y z 100zy 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Use of {99m}Tc-HMPAO in Evaluating the Results of Cerebral Hypoperfusion Prevention in the Patients with Coronary Heart Disease after Coronary Artery Bypass Grafting  |f N. Yu. Efimova [et al.] 
203 |a Text  |c electronic 
225 1 |a Radiation Technologies in Medicine 
300 |a Title screen 
330 |a The purpose of this study is to research the use of the radiopharmaceutical {99m}Tc-HMPAO in the evaluation of drug prevention of cerebral complications in patients with coronary heart disease after coronary artery bypass grafting (CABG) performed with cardiopulmonary bypass (CPB). The study included 30 patients, in whom surgical revascularization was performed with CPB. 11 patients in this group were prescribed instenon. All the patients underwent brain tomoscintigraphy with {99m}Tc-HMPAO and neuropsychological testing before CABG and 10-15 days after it. The results showed that {99m}Tc-HMPAO is useful radiopharmaceutical for evaluation of cerebral complications in patients after CABG. Thus, coronary artery bypass grafting using CPB can be complicated by the deterioration of cerebral perfusion and cognitive dysfunction, while preventive medication with instenon can prevent or significantly reduce the violations of cerebral hemodynamics and neuropsychological status of the patients. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 1 |0 (RuTPU)RU\TPU\network\4598  |t Advanced Materials Research : Radiation and nuclear techniques in material science  |o Scientific Journal 
463 1 |0 (RuTPU)RU\TPU\network\4600  |t Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)  |o The VIth International Conference, June 5-7, 2014, Tomsk, Russia  |o [proceedings]  |f National Research Tomsk Polytechnic University (TPU)  |v [P. 506-510]  |d 2015 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a головной мозг 
610 1 |a компьютерная томография 
610 1 |a эмиссионная томография 
610 1 |a шунтирование 
701 1 |a Efimova  |b N. Yu.  |c specialist in the field of medical technology  |c laboratory assistant of Tomsk Polytechnic University, Doctor of medical science  |f 1972-  |g Nataliya Yurievna  |2 stltpush  |3 (RuTPU)RU\TPU\pers\34257 
701 1 |a Chernov  |b V. I.  |c specialist in the field of medical technology  |c lead engineer of Tomsk Polytechnic University, doctor of medical sciences  |f 1962-  |g Vladimir Ivanovich  |2 stltpush  |3 (RuTPU)RU\TPU\pers\34191 
701 1 |a Efimova  |b I. Y. 
701 1 |a Akhmedov  |b S. D. 
701 1 |a Lishmanov  |b Yu. B.  |c specialist in the field of medical technology  |c lead engineer aof Tomsk Polytechnic University, doctor of medical sciences  |f 1951-  |g Yury Borisovich  |2 stltpush  |3 (RuTPU)RU\TPU\pers\34200 
712 0 2 |a Национальный исследовательский Томский политехнический университет (ТПУ)  |b Физико-технический институт (ФТИ)  |b Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯК)  |h 6471  |2 stltpush  |3 (RuTPU)RU\TPU\col\20054 
801 2 |a RU  |b 63413507  |c 20161228  |g RCR 
856 4 |u http://dx.doi.org/10.4028/www.scientific.net/AMR.1084.506 
942 |c CF